Efficacy and safety of Gegen Qinlian decoction in the treatment of type II diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials
AimThe study aims to systematically assess the efficacy and safety of Gegen Qinlian decoction in the treatment of type 2 diabetes mellitus.MethodsWe systematically searched a total of nine databases from the time of creation to 20 March 2023. The quality of the literature was assessed using the risk...
Main Authors: | YiMei Tan, ShuangHua Liu, MengHe Huang, Hui Cheng, BinBin Xu, HongSheng Luo, QiZhi Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1316269/full |
Similar Items
-
Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction
by: Jing-Ze Lu, et al.
Published: (2021-05-01) -
Gegen Qinlian Decoction treatment of asymptomatic hyperuricemia by targeting circadian immune function
by: Xiaojun Wang, et al.
Published: (2023-06-01) -
Gegen Qinlian decoction (GQD) inhibits ulcerative colitis by modulating ferroptosis-dependent pathway in mice and organoids
by: Xue Wang, et al.
Published: (2023-08-01) -
A 42-Markers Pharmacokinetic Study Reveals Interactions of Berberine and Glycyrrhizic Acid in the Anti-diabetic Chinese Medicine Formula Gegen-Qinlian Decoction
by: Xue Qiao, et al.
Published: (2018-06-01) -
Gegen Qinlian Decoction Ameliorates Hyperuricemia-Induced Renal Tubular Injury via Blocking the Inflammatory Signaling Pathway
by: Xiao-Jun Wang, et al.
Published: (2021-05-01)